Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout

NEXT STORY
Trevena Announces First Patient Enrolled in OLINVYK® Phase 3 Trial in China in Partnership with Jiangsu Nhwa Pharmaceutical
PREV STORY
Microbix Presenting Product Results to Industry
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium

author_avatar
NASDAQ Market News

Allergan and KYTHERA Announce That Pending Transaction Will Now be for All-Cash Consideration

DUBLIN, Ireland and WESTLAKE VILLAGE, Calif., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Allergan plc ...

author_avatar
NASDAQ Market News

Adverum Announces Board Slate for 2021 Annual Meeting and Reiterates Commitment to Stockholder Value Creation

author_avatar
NASDAQ Market News